User profiles for N. Chaudhry

Prof. Dr. Naveed Iqbal Chaudhry

- Verified email at pugc.edu.pk - Cited by 2033

Dr. Natalia Chaudhry

- Verified email at pucit.edu.pk - Cited by 257

Hospital waste management in developing countries: A mini review

M Ali, W Wang, N Chaudhry… - Waste Management & …, 2017 - journals.sagepub.com
… Ali M, Wang W, Chaudhry N (2016b) Comparing administration of hospital wastes using
social network analysis, MATEC Web of Conferences. EDP Sciences, p.14009. Available at: http:…

[HTML][HTML] Sepsis associated encephalopathy

N Chaudhry, AK Duggal - Advances in medicine, 2014 - hindawi.com
… Correspondence should be addressed to Neera Chaudhry; neerachaudhry@gmail.com …
Chaudhry and AK Duggal. This is an open access article distributed under the Creative …

Consensus algorithms in blockchain: Comparative analysis, challenges and opportunities

N Chaudhry, MM Yousaf - 2018 12th international conference …, 2018 - ieeexplore.ieee.org
Blockchain is a distributed ledger that gained a prevalent attention in many areas. Many
industries have started to implement blockchain solutions for their application and services. It is …

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two …

…, C Chan, E Chang, A Chang, D Chao, N Chaudhry… - The Lancet, 2022 - thelancet.com
n=334 faricimab and n=337 aflibercept), and between March 11 and Nov 1, 2019 (LUCERNE
n=331 faricimab and nn=121 [36·3%] vs n=128 [38·1%], and LUCERNE n=133 [40·2%] vs …

[HTML][HTML] Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome …

AS Soin, K Kumar, NS Choudhary… - The Lancet …, 2021 - thelancet.com
… 180 patients were recruited between May 30, 2020, and Aug 31, 2020, and randomly assigned
to the tocilizumab group (n=90) or the standard care group (n=90). One patient randomly …

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE) …

…, E Chang, J Chang, A Chang, S Charles, N Chaudhry… - The Lancet, 2022 - thelancet.com
… 3247 patients were screened for eligibility in YOSEMITE (n=1532) and RHINE (n=1715). …
n=315, RHINE n=317), faricimab PTI (n=313, n=319), or aflibercept every 8 weeks (n=312, n=…

The role of digital learning toward students' satisfaction and university brand image at educational institutes of Pakistan: a post-effect of COVID-19

…, MF Basheer, WU Hameed, NI Chaudhry - Asian Education and …, 2021 - emerald.com
Purpose This study is undertaken to examine the role of information and communication
technology (ICT), e-service quality and e-information quality towards brand image of universities …

Noninfectious endophthalmitis associated with intravitreal triamcinolone injection

…, SN Green, DL Yarian, NA Chaudhry - Archives of …, 2003 - jamanetwork.com
Background Intravitreal injection of triamcinolone has been advocated to treat exudative
macular diseases such as macular edema and choroidal neovascularization. Objective To …

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

…, P Magloire, J Neary, M Rao, PV Rahate, NK Chaudhry… - The Lancet, 2018 - thelancet.com
… Between Jan 10, 2013, and July 17, 2017, we randomly assigned 1754 patients to
receive dabigatran (n=877) or placebo (n=877); 556 patients were also randomised in the …

Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab

…, KB Freund, SD Walter, V John, R Rich, N Chaudhry… - Ophthalmology, 2020 - Elsevier
… All patients demonstrated at least 1 of the following symptoms: floaters (n = 8), reduced or
blurred vision (n = 7), scotoma (n = 3), and ocular discomfort (n = 2), and these symptoms may …